Quale sarebbe il prezzo per PharmaBlock Sciences (Nanjing), Inc. (300725)

Il prezzo per PharmaBlock Sciences (Nanjing), Inc. (300725) è $6.59

Qual è la capitalizzazione di mercato per PharmaBlock Sciences (Nanjing), Inc. (300725)

La capitalizzazione di mercato per PharmaBlock Sciences (Nanjing), Inc. (300725) è $1.54B

PharmaBlock Sciences (Nanjing), Inc. (300725) Rapporto P/B

PharmaBlock Sciences (Nanjing), Inc. delivers a comprehensive suite of chemical products and specialized services, supporting the pharmaceutical industry across the full spectrum of its operations – from initial research and development phases to large-scale commercial production. The company's primary offerings encompass: A vast inventory of chemical building blocks, available for supply at every stage of drug creation, from early discovery through to advanced development and commercial manufacturing. The creation of diverse chemical libraries, derived from their building blocks, specifically designed to accelerate drug discovery processes. Contract development and manufacturing (CDMO) services for essential pharmaceutical components, including raw starting materials (RSMs), chemical intermediates, active pharmaceutical ingredients (APIs), and finished drug products, catering to both clinical development programs and market demands. Established in 2006, PharmaBlock Sciences maintains its corporate headquarters in Nanjing, People's Republic of China.

Anno	Rapporto P/B	Cambia
Non abbastanza dati per le date fornite.

Anno

Rapporto P/B

Cambia

Non abbastanza dati per le date fornite.

Azienda	Rapporto P/B	Differenza del rapporto P/B	Il paese
MERCK Kommanditgesellschaft auf Aktien MER.SW	-	-	DE
Merck KGaA MRK.DE	-	-	DE
Takeda Pharmaceutical Company Limited 4502.T	-	-	JP
Galderma Group AG GALD.SW	-	-	CH
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	5.5207	-	IN

Azienda

Rapporto P/B

Differenza del rapporto P/B

Il paese